Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution (Q48147364)

9 February 2018

title

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution (English)

1 reference

9 February 2018

dementia with Lewy bodies

0 references

0 references

1 reference

1 reference

1 reference

1 reference

7

1 reference

9 February 2018

Clive Ballard

11

1 reference

9 February 2018

author name string

M A Piggott

1

1 reference

9 February 2018

E F Marshall

2

1 reference

9 February 2018

N Thomas

3

1 reference

9 February 2018

S Lloyd

4

1 reference

9 February 2018

J A Court

5

1 reference

9 February 2018

E Jaros

6

1 reference

9 February 2018

M Johnson

8

1 reference

9 February 2018

R H Perry

9

1 reference

9 February 2018

I G McKeith

10

1 reference

9 February 2018

E K Perry

12

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 August 1999

1 reference

9 February 2018

published in

Brain

1 reference

9 February 2018

volume

122 ( Pt 8)

1 reference

9 February 2018

issue

8

1 reference

28 June 2019

page(s)

1449-1468

1 reference

9 February 2018

Dopamine‐receptor autoradiography of human narcoleptic brain

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Changes of Biogenic Amines and Their Metabolites in Postmortem Brains from Patients with Alzheimer-Type Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

A prospective study of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Striatal dopamine receptors in Alzheimer-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

[3H]raclopride binding to brain tissue from subjects with schizophrenia: methodological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease--a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Clinical and neuropathological findings in Lewy body dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Dopamine D2 receptor imaging with SPECT using IBZM in 16 patients with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Autoradiographic distribution of D3-type dopamine receptors in human brain using [3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Molecular alterations in the neostriatum of human cocaine addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

D3 receptor expression within the basal ganglia is not affected by Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Neuroleptic malignant syndrome-like condition in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

The pharmacology of Parkinson's disease therapy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Dopamine D3 receptor mRNA and binding sites in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Pathological correlates of extrapyramidal signs in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Extrapyramidal signs in patients with probable Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

No correlation between nigral degeneration and striatal plaques in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Neuroleptic sensitivity to risperidone in Lewy body dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, Alzheimer disease, and neurologically normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Damage to dopamine systems differs between parkinson's disease and alzheimer's disease with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Changes of monoamines in post-mortem brains from patients with diffuse Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Clinical neurochemistry: developments in dementia research based on brain bank material

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D2 tracer [123I]-IBZM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Neuroleptics and dopamine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Age-dependent decline in human brain dopamine D1 and D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Striatal uptake of the dopamine reuptake ligand [ 11 C]β-CFT is reduced in Alzheimer's disease assessed by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Regional differences in chronic neuroleptic effects on extracellular dopamine activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [ 123 I]β-CIT SPECT

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

In vivo studies on striatal dopamine D 1 and D 2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Clinical and positron emission tomographic studies in the 'extrapyramidal syndrome' of dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Physical aggression is associated with preservation of substantia nigra pars compacta in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

The role of dopamine agonists in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

Extrapyramidal motor signs in clinically diagnosed Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2F122.8.1449

21 January 2018

Identifiers

DOI

10.1093/BRAIN/122.8.1449

1 reference

9 February 2018

1 reference

9 February 2018